JENNIFER BARNES: Open Payments
NPI 1366523284 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 11 payments from 8 companies in 2025. Trend: 2023 $104 · 2024 $111 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Antares Pharma, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VRAYLAR, VAXNEUVANCE, XYOSTED, GVOKE HYPOPEN, Jornay PM, FARXIGA, Cologuard Collection Kit, BEXSERO.
Industry payments across MS — which companies pay providers there.
